INOSITOL TRISPHOSPHATE RESTORES IMPAIRED HUMAN GALLBLADDER MOTILITY ASSOCIATED WITH CHOLESTEROL STONES

被引:54
作者
BEHAR, J
RHIM, BY
THOMPSON, W
BIANCANI, P
机构
[1] RHODE ISL HOSP,DEPT MED,PROVIDENCE,RI 02902
[2] RHODE ISL HOSP,DEPT SURG,PROVIDENCE,RI 02902
[3] BROWN UNIV,PROVIDENCE,RI 02912
关键词
D O I
10.1016/0016-5085(93)90427-E
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Gallbladder motility is impaired in specimens with cholesterol stones but normal with pigment stones. Methods: Muscle cells obtained from 19 human gallbladders with cholesterol stones and 11 with pigment stones were enzymatically digested and contracted with cholecystokinin octapeptide (CCK-8), acetylcholine, and KCl. Results: Muscle cells from pigment stones had a greater contraction than cells from cholesterol stones. CCK-8-induced contraction was unaffected by calcium-free media but was blocked by strontium. Potassium-evoked contraction was blocked by a calcium-free media and unaffected by strontium. Inositol triphosphate (IP-3)-induced contraction was similar to the contraction caused by CCK-8 in permeable cells from pigment stones but was greater than the response to CCK-8 in cells from cholesterol stones. Conclusions: Muscle cells from gallbladders with cholesterol stones contract less than cells from gallbladders with pigment stones; CCK-8-induced contraction only uses stored calcium; and IP-3 causes contractions of equal magnitude in cells from gallbladders with cholesterol and pigment stones. These abnormalities could result from an impaired receptor activation of the mechanism for IP-3 generation and release of stored calcium. © 1993.
引用
收藏
页码:563 / 568
页数:6
相关论文
共 34 条
  • [11] DOTY JE, 1983, GASTROENTEROLOGY, V85, P168
  • [12] ABNORMAL GALLBLADDER EMPTYING IN PATIENTS WITH GALLSTONES
    FISHER, RS
    STELZER, F
    ROCK, E
    MALMUD, LS
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1982, 27 (11) : 1019 - 1024
  • [13] FRIDHANDLER TM, 1983, GASTROENTEROLOGY, V85, P830
  • [14] GHOSH TK, 1988, J BIOL CHEM, V263, P11075
  • [15] GUILLEMETTE G, 1989, MOL PHARMACOL, V35, P339
  • [16] HOKINNEAVERSON M, 1984, J BIOL CHEM, V259, P4346
  • [17] HOLAN KR, 1979, GASTROENTEROLOGY, V77, P611
  • [18] KRAMER RM, 1982, J BIOL CHEM, V257, P6844
  • [19] LAMORTE WW, 1979, GASTROENTEROLOGY, V77, P580
  • [20] LAMORTE WW, 1985, SURGERY, V98, P445